Erica Schleifman

Senior Director, Cancer Biomarker Development
AstraZeneca

Disclosure information not submitted.

Presentation(s):

• Molecular Residual Disease (MRD): The Current Landscape, Key Challenges, and Future Opportunities

  Wednesday, November 12, 2025
  11:00 AM - 11:50 AM EST